As-Is and Construction Inspection Process Map

The National Cancer Institute (NCI), a component of the Department of Health and Human Services, is seeking a contractor to develop a comprehensive Process Map addressing deficiencies in architectural and mechanical, electrical, and plumbing (MEP) documentation for campus construction projects. The primary objectives include creating detailed procedures for surveying existing conditions, documenting architectural and MEP systems, and establishing a robust inspection program for construction projects. The contract requires developing two critical deliverables: a Process Map for AS-IS drawings and an Inspection Program Process Map, both of which must be completed within three weeks of contract award. Contractors will need to review existing documentation, develop detailed process flows, and ensure seamless coordination between architectural/engineering firms, construction contractors, and NIH. The procurement falls under the Surveying and Mapping Services NAICS category (541370) and will require comprehensive stakeholder engagement and approval processes.

This pre-solicitation notice indicates no specific set-aside designations for the contract, suggesting it is open to all qualified contractors. The contract is structured for a relatively short-term engagement, with initial deliverables expected within three weeks of award. While specific budget ranges are not explicitly stated, the complexity of developing comprehensive process maps for a major research campus suggests a potentially significant professional services contract. The opportunity is currently in the pre-solicitation phase, with responses due by December 17, 2024. The procurement will likely involve a competitive selection process that evaluates contractors' capabilities in process mapping, technical documentation, and understanding of complex institutional construction management requirements. Interested firms should carefully review the Statement of Work to ensure they can meet the technical and procedural specifications outlined by the National Cancer Institute.